|
| Study | Sample size (treatment/control) | Diagnosis standard | Complications | Intervention | Control | Treatment course (month) | Clinical standards | Outcome measure |
|
Huang 2009
[13] | 64 (32/32) | Diagnosis criteria for FPVC
(>720/24 h) | Elderly FPVC | SSYX Capsule 1.6 g tid
+ Control | Amiodarone
200 mg, tid for 4 d; 200 mg, bid for 3 d; 200 mg, qd for 14 d; 100 mg, qd for maintenance treatment | 1 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; ADR |
Guo
2008
[14] | 26 (13/13) | Diagnosis criteria for FPVC
(unclear) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Amiodarone
200 mg, tid for 7 d; 200 mg, bid for 7 d; 200 mg, qd for maintenance treatment | 3 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; ADR |
Zhu et al. 2012
[15] | 49 (28/21) | ACC/AHA/HRS
(2008) | Sick Sinus Syndrome and FPVC | SSYX Capsule 1.6 g tid
+ Control | Conventional therapy with antiarrhythmic drugs (no detailed information) | 2 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; Number of Ventricular Premature Beat; ADR |
|
Ping et al. 2012 [16] | 56 (28/28) | Diagnosis criteria for FPVC
(>720/24 h) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Amiodarone
200 mg, tid for 7 d; 200 mg, bid for 14 d; 200 mg, qd for maintenance treatment | 4 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC |
Su and Wang 2007
[17] | 60 (30/30) | Diagnosis criteria for FPVC
(>30/h) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Mexiletine
12.5 mg, bid | 4 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; Number of Ventricular Premature Beat; ADR |
Yu et al. 2009
[18] | 62 (32/30) | Diagnosis criteria for FPVC
(>5/min) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 2 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC |
Zhou and Li 2011
[19] | 70 (35/35) | Diagnosis criteria for FPVC
(>30/h) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 1 | 24 h Holter | Total effect for FPVC; Number of Ventricular Premature Beat |
Geng et al. 2011
[20] | 70 (35/35) | Diagnosis criteria for FPVC
(>1000/24 h) | Elderly FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 4 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; Number of Ventricular Premature Beat; ADR |
Zhou 2013
[21] | 36 (18/18) | Diagnosis criteria for FPVC
(unclear) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 2 | 24 h Holter | Total effect for FPVC |
Wan 2012
[22] | 38 (20/18) | Diagnosis criteria for FPVC
(unclear) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 4 | 24 h Holter | Total effect for FPVC; ADR |
Fu et al. 2010
[23] | 204 (106/98) | Diagnosis criteria for FPVC
(7200/24 h) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Amiodarone
200 mg, tid for 3 d; 100 mg, bid for 3 d; 100 mg, qd for maintenance treatment | 6 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; ADR |
Qiu et al. 2012
[24] | 65 (33/32) | Diagnosis criteria for FPVC
(>30/h) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 2 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; Number of Ventricular Premature Beat; ADR |
Li and Yan 2009
[25] | 60 (30/30) | Diagnosis criteria for FPVC
(unclear) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Propafenone
150 mg, tid | 3 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC |
Fu et al. 2010
[26] | 72 (37/35) | Diagnosis criteria for FPVC
(>30/h) | Elderly FPVC | SSYX Capsule 1.6 g tid
+ Control | Amiodarone
200 mg, tid for 7 d; 200 mg, bid for 14 d; 200 mg, qd for 21 d; 100–200 mg, qd for maintenance treatment | 4 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; ADR |
|
Zhang et al. 2011 [27] | 128 (64/64) | Diagnosis criteria for FPVC
(unclear) | FPVC | SSYX Capsule 1.6 g tid
+ Control | Metoprolol
12.5 mg, bid | 4 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC; ADR |
Liu and Li 2011
[28] | 55 (30/25) | Diagnosis criteria for FPVC
(unclear) | Elderly FPVC | SSYX Capsule 1.6 g tid
+ Control | Propafenone
100–150 mg, tid | 2 | Clinical research guideline of medicine for cardiovascular system by Ministry of Public Health (1998) | Total effect for FPVC |
|
